Sicard Pierre, Oudot Alexandra, Guilland Jean-Claude, Moreau Daniel, Vergely Catherine, Rochette Luc
Laboratoire de Physiopathologie et Pharmacologie Cardio-vasculaires Expérimentales, IFR no. 100, Facultés de Médecine et de Pharmacie, 7, Boulevard Jeanne d'Arc, 21000 Dijon, France.
Vascul Pharmacol. 2006 Aug;45(2):112-21. doi: 10.1016/j.vph.2006.04.001.
It has not been completely demonstrated if hypertension may, in part, develop as a result of increased oxidative stress (OS), inflammation and little is known about the short-term effects of antioxidant therapy. This study was designed to appreciate the effect of 7 days vitamin C-enriched diet (5 g/kg/day) on hemodynamic function and vascular OS in normotensive Wistar Kyoto rats and hypertensive rats (SHR). Aorta NAD(P)H oxidase activity was determinate and free radicals evaluated by electron spin resonance with a spin probe CP-H. Matrix metalloproteinase-1 (MMP-1) and monocyte chemoattractant protein-1 (MCP-1) expression were measured. The treatment with vitamin C did not change arterial pressure in SHR but prevented the increase in OS levels in SHR aortas. MMP-1 and MCP-1 expressions were more intense in the media of SHR aortas than in those of WKY rats but these expressions were not modified by vitamin C-pretreatment. Vitamin C-pretreatment was not able to protect heart against in vitro ischemia-reperfusion dysfunctions. These data may suggest that treatment with high doses of vitamin C in SHR can limit over-production of reactive oxygen species; however this effect was not accompanied with changes in arterial pressure and protection against I-R dysfunctions. Dissociation between vascular oxidative stress and cardiovascular function may be evoked.
高血压是否部分由氧化应激(OS)增加和炎症导致,目前尚未完全证实,而且对抗氧化治疗的短期效果知之甚少。本研究旨在评估富含维生素C的饮食(5克/千克/天)对正常血压的Wistar Kyoto大鼠和高血压大鼠(SHR)的血流动力学功能和血管氧化应激的影响。通过自旋探针CP-H用电子自旋共振法测定主动脉NAD(P)H氧化酶活性并评估自由基。检测基质金属蛋白酶-1(MMP-1)和单核细胞趋化蛋白-1(MCP-1)的表达。维生素C治疗并未改变SHR的动脉血压,但可防止SHR主动脉中OS水平升高。SHR主动脉中层中MMP-1和MCP-1的表达比WKY大鼠的更强烈,但维生素C预处理并未改变这些表达。维生素C预处理无法保护心脏免受体外缺血-再灌注功能障碍的影响。这些数据可能表明,高剂量维生素C治疗SHR可限制活性氧的过度产生;然而,这种作用并未伴随着动脉血压的变化以及对缺血-再灌注功能障碍的保护作用。可能会引发血管氧化应激与心血管功能之间的分离。